In these experiments, Berger and colleagues show that somatic PREX2 mutations identified through whole - genome sequencing of human
melanoma can contribute to enhanced lethality of tumor
xenografts in nude mice (Figure 3B, S6B, and S6C; Berger et al., 2012).